MEP11608A - Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures - Google Patents

Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures

Info

Publication number
MEP11608A
MEP11608A MEP-116/08A MEP11608A MEP11608A ME P11608 A MEP11608 A ME P11608A ME P11608 A MEP11608 A ME P11608A ME P11608 A MEP11608 A ME P11608A
Authority
ME
Montenegro
Prior art keywords
mixtures
heparin
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
MEP-116/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Volker Laux
Pierre Mourier
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MEP11608A publication Critical patent/MEP11608A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MEP-116/08A 2003-07-24 2004-07-22 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures MEP11608A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0309041A FR2857971B1 (fr) 2003-07-24 2003-07-24 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
YUP-2006/0044A RS20060044A (sr) 2003-07-24 2004-07-22 Smeše oligosaharida izvedene od heparina, njihovo dobijanje i farmaceutski preparati koji sadrže ove smeše
PCT/FR2004/001943 WO2005010051A2 (fr) 2003-07-24 2004-07-22 Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
MEP11608A true MEP11608A (en) 2010-06-10

Family

ID=33561051

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-116/08A MEP11608A (en) 2003-07-24 2004-07-22 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures

Country Status (39)

Country Link
EP (1) EP1651677B1 (enrdf_load_stackoverflow)
JP (1) JP4865552B2 (enrdf_load_stackoverflow)
KR (1) KR101125517B1 (enrdf_load_stackoverflow)
CN (1) CN1852926B (enrdf_load_stackoverflow)
AR (1) AR045917A1 (enrdf_load_stackoverflow)
AT (1) ATE487741T1 (enrdf_load_stackoverflow)
AU (1) AU2004259111B2 (enrdf_load_stackoverflow)
BR (1) BRPI0412850A (enrdf_load_stackoverflow)
CA (1) CA2533555A1 (enrdf_load_stackoverflow)
CR (1) CR8201A (enrdf_load_stackoverflow)
CY (1) CY1111165T1 (enrdf_load_stackoverflow)
DE (1) DE602004030015D1 (enrdf_load_stackoverflow)
DK (1) DK1651677T3 (enrdf_load_stackoverflow)
EC (1) ECSP066305A (enrdf_load_stackoverflow)
ES (1) ES2355827T3 (enrdf_load_stackoverflow)
FR (1) FR2857971B1 (enrdf_load_stackoverflow)
GT (1) GT200400145A (enrdf_load_stackoverflow)
HN (1) HN2004000250A (enrdf_load_stackoverflow)
IL (1) IL173206A (enrdf_load_stackoverflow)
MA (1) MA27928A1 (enrdf_load_stackoverflow)
ME (1) MEP11608A (enrdf_load_stackoverflow)
MX (1) MXPA06000336A (enrdf_load_stackoverflow)
MY (1) MY136769A (enrdf_load_stackoverflow)
NO (1) NO20060821L (enrdf_load_stackoverflow)
NZ (1) NZ544717A (enrdf_load_stackoverflow)
OA (1) OA13197A (enrdf_load_stackoverflow)
PA (1) PA8606801A1 (enrdf_load_stackoverflow)
PE (1) PE20050246A1 (enrdf_load_stackoverflow)
PL (1) PL1651677T3 (enrdf_load_stackoverflow)
PT (1) PT1651677E (enrdf_load_stackoverflow)
RS (1) RS20060044A (enrdf_load_stackoverflow)
RU (1) RU2346005C2 (enrdf_load_stackoverflow)
SI (1) SI1651677T1 (enrdf_load_stackoverflow)
TN (1) TNSN06025A1 (enrdf_load_stackoverflow)
TW (1) TWI369208B (enrdf_load_stackoverflow)
UA (1) UA89356C2 (enrdf_load_stackoverflow)
UY (1) UY28435A1 (enrdf_load_stackoverflow)
WO (1) WO2005010051A2 (enrdf_load_stackoverflow)
ZA (1) ZA200600657B (enrdf_load_stackoverflow)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589145B2 (en) 2004-04-15 2009-09-15 Exxonmobil Chemical Patents Inc. Syndiotactic rich polyolefins
JP2009538386A (ja) * 2006-05-25 2009-11-05 モメンタ ファーマシューティカルズ インコーポレイテッド 低分子量ヘパリン組成物およびその使用
CN101711771B (zh) * 2008-10-07 2015-12-09 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制法和药物组合物
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
WO2012072799A1 (en) 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
CN102558392A (zh) * 2010-12-14 2012-07-11 王芃 一种高抗FXa、低抗FIIa低分子肝素钠的制备方法
CN102816255B (zh) * 2011-06-10 2015-11-25 王芃 一种超低分子肝素钠的制备方法
US9896517B2 (en) 2013-03-26 2018-02-20 Jiuzhitang Co., Ltd. Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
CN103864959A (zh) * 2014-04-03 2014-06-18 中国药科大学 一种肝素十二糖抗动脉粥样硬化的用途
RU2639574C2 (ru) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Способ получения низкомолекулярного гепарина

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2504928A1 (fr) * 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
IT1284143B1 (it) * 1996-09-06 1998-05-08 Istituto Scient Di Chimica E B Eparansolfati semi-sintetici ad elevata attivita' antimetastica e ridotto rischio emorragico
US6075013A (en) * 1997-06-06 2000-06-13 Hamilton Civic Hospitals Research Development Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
FR2807043B1 (fr) * 2000-03-28 2002-11-22 Aventis Pharma Sa Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
JP2005505537A (ja) * 2001-08-28 2005-02-24 レオ・ファーマ・アクティーゼルスカブ 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
TNSN06025A1 (en) 2007-10-03
ATE487741T1 (de) 2010-11-15
AU2004259111B2 (en) 2009-06-11
UY28435A1 (es) 2005-02-28
UA89356C2 (ru) 2010-01-25
ES2355827T3 (es) 2011-03-31
HN2004000250A (es) 2006-06-29
MA27928A1 (fr) 2006-06-01
CN1852926B (zh) 2010-05-12
JP2006528614A (ja) 2006-12-21
GT200400145A (es) 2005-03-16
EP1651677A2 (fr) 2006-05-03
AU2004259111A1 (en) 2005-02-03
SI1651677T1 (sl) 2011-03-31
CY1111165T1 (el) 2015-06-11
RU2006105384A (ru) 2007-09-10
AR045917A1 (es) 2005-11-16
RU2346005C2 (ru) 2009-02-10
HK1094806A1 (zh) 2007-04-13
DK1651677T3 (da) 2011-02-28
FR2857971A1 (fr) 2005-01-28
OA13197A (fr) 2006-12-13
NO20060821L (no) 2006-04-20
PE20050246A1 (es) 2005-06-02
CN1852926A (zh) 2006-10-25
FR2857971B1 (fr) 2005-08-26
RS20060044A (sr) 2008-06-05
CR8201A (es) 2006-09-22
TWI369208B (en) 2012-08-01
KR101125517B1 (ko) 2012-03-23
NZ544717A (en) 2009-09-25
WO2005010051A2 (fr) 2005-02-03
PT1651677E (pt) 2011-02-08
PL1651677T3 (pl) 2011-04-29
EP1651677B1 (fr) 2010-11-10
IL173206A (en) 2010-11-30
JP4865552B2 (ja) 2012-02-01
ECSP066305A (es) 2006-07-28
ZA200600657B (en) 2007-05-30
MY136769A (en) 2008-11-28
CA2533555A1 (fr) 2005-02-03
KR20060059974A (ko) 2006-06-02
BRPI0412850A (pt) 2006-10-03
MXPA06000336A (es) 2006-03-30
PA8606801A1 (es) 2005-02-04
WO2005010051A3 (fr) 2005-06-16
DE602004030015D1 (de) 2010-12-23
TW200522970A (en) 2005-07-16
IL173206A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
DE60323756D1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
BR0112612A (pt) Misturas de polissacarìdeos sulfatados, processo de preparação das mesmas e composições farmacêuticas
BRPI0411670A (pt) método para preparar hidrocolóides de galactomanana, hidrocolóide de galactomanana, composição, uso do hidrocolóide de galactomanana, produto para cuidado pessoal, produto para cuidado da saúde ou produto tópico para cuidado da saúde, produto para cuidados domésticos, produto institucional e industrial, e, método para purificar hicrocolóides de galactomanana
MEP35808A (en) New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders
BR0116047A (pt) Imidazoquinolinas substituìdas de éter heterocìclico
MEP11608A (en) Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
MEP10408A (en) Platinum derivative pharmaceutical formulations
NO20052071L (no) Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer.
HRP20050690A2 (en) Hiv inhibiting 1,2,4-triazines
DE60117777D1 (de) Acylierte zyklodextrin guest-inklusion komplexe
NO20073101L (no) Nye pyridinforbindelser
BRPI0109200B8 (pt) compostos e composições farmacêuticas
BR0208741A (pt) Derivados de piperidina
BR0211995A (pt) Preparados de combinação de derivados de propanolamina substituìdos por arila com outras substâncias ativas e sua aplicação
NO20005497L (no) Heterocykliske derivater som inhiberer faktor Xa
NO20075637L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet
BRPI0519620A2 (pt) compostos, processo para a sua manufatura, composiÇÕes farmacÊuticas que os compreendem, mÉtodo para o tratamento terapÊutico e/ou profilÁtico de enfermidades que sço moduladas por agonistas alfa-lxr e/ou beta-lxr e utilizaÇço desses compostos
NO20010940D0 (no) TAN-1057 derivater
HRP20060127A2 (en) Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
HRP20041192B1 (hr) POSTUPAK PRIPRAVE PIROKSIKAM/Ăź-CIKLODEKSTRIN INKLUZIJSKIH SPOJEVA
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
BRPI0406804A (pt) 4-cetolactamas e -lactonas trussubstituìdas substituìdas por 3-fenila
BR0006230B1 (pt) Composição na forma de um pó ou grânulos compreendendo ácido ascórbico e pectina, e processo para sua preparação